PD

Prosenjit Debnath

Active Director Director DIN 10081401
DIN 10081401 First appointment Mar 2023 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Prosenjit Debnath

Data last updated:

Prosenjit Debnath is a Director at Dr B Pharmaceutical Private Limited (since 2023). The company operates in Pharma.

DIN 10081401
Primary Designation Director
Industry Pharma
First Appointment 20 Mar 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Dr B Pharmaceutical Private Limited U47721AS2023PTC024291
Director20 Mar 20232023Active

Board colleagues of Prosenjit Debnath

NameDINCompanyDesignation
Ratan Debnath10081402Dr B Pharmaceutical Private LimitedDirector

Directorship timeline

Open interactive timeline →
Dr B Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Prosenjit Debnath

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Prosenjit Debnath

Prosenjit Debnath currently holds 1 directorship: Dr B Pharmaceutical Private Limited (Director, since 20 Mar 2023).

Prosenjit Debnath was first appointed on 20 Mar 2023 as Director at Dr B Pharmaceutical Private Limited.

The current boards of Prosenjit Debnath's companies include Ratan Debnath (Dr B Pharmaceutical Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available